Rolf Karl Richard Nilsson
Plus aucun poste en cours
Profil
Rolf Karl Richard Nilsson formerly worked at Arterion AB, as Chief Executive Officer from 2007 to 2013, Acosense AB, as Chief Executive Officer from 2019 to 2022, and Parans Solar Lighting AB, as Chief Technical Officer from 2015 to 2017.
Mr. Nilsson received his graduate degree from Chalmers University of Technology.
Anciens postes connus de Rolf Karl Richard Nilsson
| Sociétés | Poste | Fin |
|---|---|---|
| ACOSENSE AB (PUBL) | Directeur Général | 01/07/2022 |
| PARANS SOLAR LIGHTING AB (PUBL) | Directeur Technique/Scientifique/R&D | 01/05/2017 |
Arterion AB
 Arterion AB BiotechnologyHealth Technology Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden. | Directeur Général | 01/08/2013 |
Formation de Rolf Karl Richard Nilsson
| Chalmers University of Technology | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACOSENSE AB (PUBL) | Electronic Technology |
| Entreprise privées | 2 |
|---|---|
Parans Solar Lighting AB
 Parans Solar Lighting AB Miscellaneous Commercial ServicesCommercial Services Parans Solar Lighting AB engages in the development and sale of an environmental system. Its products include Parans Luminaire and Parans SP4. The company was founded in 2003 and is headquartered in Moelndal, Sweden. | Commercial Services |
Arterion AB
Arterion AB BiotechnologyHealth Technology Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden. | Health Technology |
